MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

Search

Biomerica Inc

Închisă

0.52 -7.14

Rezumat

Modificarea prețului

24h

Curent

Minim

0.48

Maxim

0.57

Indicatori cheie

By Trading Economics

Venit

366K

-950K

Vânzări

-171K

1.6M

EPS

-0.056

Marjă de profit

-58.068

Angajați

64

EBITDA

278K

-993K

Statistici piață

By TradingEconomics

Capitalizare de piață

5.5M

Deschiderea anterioară

7.66

Închiderea anterioară

0.52

Scor tehnic

By Trading Central

Încredere

Very Strong Bearish Evidence

Biomerica Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

3 apr. 2025, 23:04 UTC

Top știri

JPMorgan Raises Risk of U.S., Global Recession to 60%

3 apr. 2025, 22:40 UTC

Principalele dinamici ale pieței

Aldeyra Shares Fall on FDA Complete Response Letter for Dry Eye Disease Drug

3 apr. 2025, 22:18 UTC

Achiziții, Fuziuni, Preluări

Quantum Corp. Gets Strategic Investment, Names New Financial Chief

3 apr. 2025, 18:51 UTC

Achiziții, Fuziuni, Preluări

Capital One, Discover Merger Clears Regulatory Hurdle, Sources Tell The New York Times

3 apr. 2025, 23:43 UTC

Market Talk

Gold Steady, Supported by Potential Safe-Haven Demand -- Market Talk

3 apr. 2025, 23:41 UTC

Market Talk

Nikkei May Fall as U.S. Tariffs Raise Concerns About Global Growth -- Market Talk

3 apr. 2025, 22:22 UTC

Achiziții, Fuziuni, Preluări

Is TikTok Getting Banned? What to Expect as the Deadline Approaches. -- Barrons.com

3 apr. 2025, 22:21 UTC

Achiziții, Fuziuni, Preluări

Is TikTok Getting Banned? What to Expect as the Deadline Approaches. -- Barrons.com

3 apr. 2025, 21:43 UTC

Top știri
Câștiguri

The Day Trump's Tariffs Shook Wall Street and Corporate America -- 5th Update

3 apr. 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

3 apr. 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

3 apr. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

3 apr. 2025, 20:43 UTC

Market Talk

Plummeting Toronto Home Sales Reflect Trade, Political Uncertainty -- Market Talk

3 apr. 2025, 20:34 UTC

Top știri

Trump's Tariffs Were Supposed to Boost the Dollar, But Here's Why the Opposite Happened -- Heard on the Street -- 2nd Update

3 apr. 2025, 20:23 UTC

Top știri

Trump Tariffs Send Dow Industrials to 1600-Point Decline; Dollar Slumps -- WSJ

3 apr. 2025, 20:15 UTC

Achiziții, Fuziuni, Preluări

Blackstone Life Sciences And Anthos Therapeutics Announce Novartis Has Completed The Acquisition Of Anthos Therapeutics In A Deal Valued At Up To $3.1B, With $925M Paid Upfront >BX

3 apr. 2025, 19:55 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

3 apr. 2025, 19:55 UTC

Market Talk

Dollar Weakens as Investors Seek Safety Elsewhere -- Market Talk

3 apr. 2025, 19:21 UTC

Market Talk

Oil Futures Slide on U.S. Tariffs, OPEC+ Output Plan -- Market Talk

3 apr. 2025, 19:15 UTC

Market Talk

U.S. Natural Gas Stays Focused on Weather, Storage -- Market Talk

3 apr. 2025, 18:45 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

3 apr. 2025, 18:45 UTC

Market Talk

Gold Drops In Tariff Fallout -- Market Talk

3 apr. 2025, 18:39 UTC

Market Talk

U.S. Tariffs Could Give Natural Gas Edge Over Solar -- Market Talk

3 apr. 2025, 18:38 UTC

Top știri

Trump Tariffs Send Dow Industrials to 1400-Point Decline; Dollar Slumps -- WSJ

3 apr. 2025, 18:30 UTC

Top știri

Auto Industry Braces for Major Pain From Trump's Tariffs -- Analysis

3 apr. 2025, 18:20 UTC

Market Talk

Uncertainty Still Roils Companies in Tariff Saga -- Market Talk

3 apr. 2025, 18:18 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

3 apr. 2025, 18:17 UTC

Market Talk

U.S. Workers Can't Match International Labor as Companies Consider Moving Supply Chains -- Market Talk

3 apr. 2025, 18:04 UTC

Market Talk

US Sees More Job Openings in Construction, Transportation -- Market Talk

3 apr. 2025, 17:55 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

Comparație

Modificare preț

Biomerica Inc Așteptări

Scor tehnic

By Trading Central

0.5528 / 0.71Suport & Rezistență

Termen scurt

Very Strong Bearish Evidence

Termen mediu

Bullish Evidence

Termen lung

Strong Bullish Evidence

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Biomerica Inc

Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies, antigens, and other substances which may exist in the human body, stools, or blood in extremely small concentrations. It primarily sells its products for treating gastrointestinal diseases and food intolerances, as well as various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also involved in the development of InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and hp+detect, a H. Pylori diagnostic test that indicates if a patient is infected with the H. Pylori bacteria. In addition, it develops, markets, and sells COVID-19 diagnostic tests to indicate if a person has been infected by COVID-19. The company was incorporated in 1971 and is headquartered in Irvine, California.